Harmony Biosciences Holdings, Inc. (HRMY)
Nasdaq: HRMY · Pharmaceutical Preparations · Plymouth Meeting, PA · filing with the SEC since 2020
Grade7.0
◀ Past 8.4● Present 6.9▶ Future 5.6
Who owns Harmony Biosciences Holdings, Inc.
As filed with the SECHolders of 5% or more
4
Blackrock, Inc. holds 12.6% of Common Stock, as its SCHEDULE 13G/A filed Oct 27, 2026 says.
Directors and officers
16
report now, of 23 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 27, 2026 · Common Stock · 11.3% in Jul 28, 2026
Marshman Fund Trust II
SCHEDULE 13G/A · filed Feb 10, 2025 · Common Stock, par value $0.00001 per share
Fmr LLC
SCHEDULE 13G/A · filed Feb 5, 2026 · COMMON STOCK · 6.7% in Nov 5, 2025
Vanguard Portfolio Management
SCHEDULE 13G · filed Jul 31, 2026 · Common Stock
Antonio J. Gracias
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, $0.00001 par value per share · reported falling below 5%, from 11.7% in Feb 12, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 8.3% in Jan 30, 2025
What HRMY reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Epygenix Acquisition
A company bought · asset acquisition · owns, named in the 10-K filed Feb 24, 2026
Zynerba Acquisition
A company bought · asset acquisition · owns, named in the 10-K filed Feb 24, 2026
4 subsidiaries in 2 countries, from the list filed with the 10-K filed Feb 24, 2026.
Insider tradesForm 4
13sales
0purchases
6sales on a scheduled plan
3people selling
$6.0Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 32 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Budur Kumar | CHIEF MEDICAL OFFICER | 7 | $3.1M | 0 | 0 | $0 |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | 4 | $1.8M | 4 | 0 | $0 |
| Dayno Jeffrey M. | PRESIDENT, CEO | 2 | $1.0M | 2 | 0 | $0 |